AnorMED announces 73% of cancer patients who failed prior chemotherapy mobilizations succeed in collecting enough stem cells for transplant in MOZOBIL compassionate use program
12th Dec 2005, 18:21 GMT
AnorMED announces the 1st report of clinical results on MOZOBIL, a 1st in class stem cell mobilizer, from the compassionate use protocol in cancer patients requiring a stem cell transplant.
AnorMED announces 73% of cancer patients who failed prior chemotherapy mobilizations succeed in collecting enough stem cells for transplant in MOZOBIL compassionate use program related news:
- Fascinating news about cancer stem cells — The Cancer Blog
- Stem cell booster drug may prove a help to cancer patients — The Diabetes Blog
- Adding Radioimmunotherapy To Chemotherapy Reduces Relapse Risk In Mantle Cell Leukemia Patients — Medical News Today RSS/XML Feed
- Low-dose Chemotherapy Plus Antiangiogenesis Drug Has Activity In Advanced Breast Cancer — ScienceDaily Headlines: Health & Medicine
- Breast cancer treatment changing — The Cancer Blog
- Vaccine Given To Healthy Donors May Protect Bone Marrow Transplant Patients — Medical News Today RSS/XML Feed
- Researchers Discover Potential Mechanism For Tumor Growth — ScienceDaily Headlines: Health & Medicine
- Columbia University Medical Center researchers discover potential mechanism for tumor growth — EurekAlert! - Biology
- An obstacle to cancer cells — EurekAlert! - Biology
- Target for cancer therapy: proliferating cells or stem cells — Leukemia
Latest news from StratWire - Business of Healthcare NewsFeed:
- Alliance Names New COO
- NHCAA to Award Those Who Fight and Expose the Deadly Side of Health Care Fraud
- More Than 2 mln Cancer Patients Treated with BrainLAB m3 Shaped Beam Radiosurgery
- PA's Continuing Trend Towards Total Body Reconstruction Keeps Consumers Demanding Comprehensive Direct-To-Consumer-Education (DTCE )
- Dr Farzad Yaghouti of Global Laser Vision San Diego Wins 'Best Lasik Surgeon 2006'
- 1st Study to Evaluate WelChol/Ezetimibe and Simvastatin Effect on LDL-C Finds Additional Lipid Parameter Benefits
- Medical Mutual of OH Financial Investigator Wins Top Nat'l Fraud-Fighting Award
- Intelligent Medical Objects and Bond Technologies Sign Multi-year Agreement
- M-CARE's Medicaid Plan Recognized as One of the Top Health Plans by US News & World Report/NCQA
- Fitch: MCH rates 'A-' on bonds